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Spontaneous regression of cancer is a rare phenomenon. We present a rare case of pulmonary metastases in a 72-year-old woman
with metastatic breast angiosarcoma. She was diagnosed with a breast angiosarcoma in 2005 and underwent a total mastectomy
and postoperative radiotherapy. Unfortunately, a year later she was found to have multiple lung and scalp metastases but in a view
of her poor general ﬁtness, she was not a candidate for chemotherapy and was kept on regular followup. Despite the absence of any
treatment, the followup chest X-ray showed a signiﬁcant reduction in the number and size of lung nodules and her scalp lesions
regressed completely. Seven months after the diagnosis of metastatic disease, the nodules in her scalp remain controlled.
Copyright © 2008 S. W. Kim and J. Wylie. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Spontaneous regression (SR) of cancer is a rare but well-
known phenomenon, which has been reported in several
types of human cancer. It has been most commonly reported
in carcinoma of the kidney, neuroblastoma, malignant
melanoma, and choriocarcinoma [1]. We present a case
of spontaneous regression of pulmonary metastases from a
primary breast angiosarcoma.
2. CASE REPORT
A 72-year-old lady presented to a local emergency depart-
ment with an ulcerating bruised lesion in her left breast
(Figure 1). A true-cut biopsy of the mass conﬁrmed an
angiosarcoma and she subsequently underwent a left simple
mastectomy in June 2005. The ﬁnal histology showed a
40mm ulcerated lesion showing the typical features of an
epithelioid angiosarcoma. The tumour was predominantly
well diﬀerentiated with smaller areas showing poorly diﬀer-
entiated tumour cells. The tumour was excised completely
but the closest posterior margin was only 1mm. Following
referral to our institution, postoperative radiotherapy was
delivered to the chest wall using a single 8Mev electron ﬁeld,
delivering 40Gy in 15 fractions over 3 weeks followed by an
electron boost to the scar of 10Gy in 4 fractions. A staging
CT thorax and abdomen at this time showed no evidence of
distant metastases.
Unfortunately, in May 2006, the patient presented to the
clinic with symptoms of shortness of breath and a chest
radiograph revealed multiple lung metastases. A subsequent
CT scan showed multiple bilateral lung nodules considered
too numerous to consider metastectomy. Due to the patient’s
poor general ﬁtness, she was not a candidate for chemother-
apy but was kept on regular follow-up. Over the next few
months, she developed symptoms of disease progression and
the repeated chest X-rays showed an increase in the size and
number of lung nodules (Figure 2). Physical examination at
that time also revealed multiple new subcutaneous nodules
onherscalpconsistentwithmetastaticskindeposits.Asthese
nodules were not causing her any symptoms, no palliative
treatment was oﬀered at that time.
She was reviewed again in the clinic in December 2007
and commented that the scalp nodules had regressed. On
clinical examination, the subcutaneous scalp nodules were
no longer palpable and a subsequent chest X-ray showed
a reduction in the number and size of lung nodules. The
patient denied taking any nonprescribed medication or
dietarychangeleadingtotheconclusionthatthisrepresented
a spontaneous regression (Figure 3).2 Sarcoma
Figure 1: An ulcerated bruise-like lesion in the left breast,
consistent with the typical appearance of a breast angiosarcoma.
Figure 2: Chest radiograph showing multiple lung metastases.
3. DISCUSSION
Primary sarcoma of the breast is a rare malignant tumour
which accounts for approximately 0.04% of all breast
tumours [2]. It typically presents as a palpable breast
mass and the highly vascular nature of these tumours
often produces a bluish discoloration of the overlying skin.
The discoloration is often initially mistaken for bruising,
therebydelayingdiagnosis.Theprimarytreatmentissurgical
excision, which often requires a simple mastectomy in order
to obtain wide margins. A routine axillary dissection is not
indicated as lymphatic spread is uncommon (although more
common than many other sarcomas) [3].
There has been an increased incidence of soft tissue sar-
comasinbreastcancerpatientswhounderwentradiotherapy
Figure 3: Repeat chest radiograph performed three months later
showing a signiﬁcant reduction in size and number of lung
metastases.
treatments [4–6]. One study reported 16-fold increased risk
of angiosarcoma and 2-fold increased risk of other sarcomas
in postradiotherapy patients [6].
A positive surgical margin is an important risk factor for
disease recurrence, and the use of adjuvant radiotherapy has
shown to be related to reduce local recurrence [7]. Although
radiotherapy has not shown to improve survival, given the
well-known beneﬁt of radiotherapy in soft tissue sarcomas
at other tumour sites, it is reasonable to oﬀer postoperative
radiotherapy if there is high risk of microscopic residual
disease [7]. The prognostic factors for sarcoma of the breast
include the tumour grade, size, presence of residual disease,
and cellular pleomorphism [8, 9]. There is no deﬁnite
evidence to support the use of adjuvant chemotherapy in
angiosarcoma [9].
Spontaneous regression (SR) of cancer is deﬁned as a
partial or complete disappearance of a malignant tumour
in the absence of medical treatment or in the presence of
treatment which is considered to be inadequate to produce
a signiﬁcant inﬂuence on tumour regression [10]. Several
mechanisms have been proposed to explain SR of cancer.
These include stimulation of an immune response, the elim-
ination of carcinogens, angiogenesis inhibition, hormonal
mediation, enhanced apoptosis, and epigenetic mechanisms
[11].
In normal endothelial cells, there is a balance between
endogenous proangiogenic factors and antiangiogenic fac-
tors. An increased expression of proangiogenic factor, such
as vascular endothelial growth factor (VEGF), can be seen
in cancer cells leading to the uncontrolled growth of blood
vessels promoting the further growth of tumour cells.
Angiostatin, a naturally occurring antiangiogenic factor, has
shown to suppress the tumour growth in several animal
studies [12], and there is experimental evidence showing
the increased growth of micrometastases when endogenous
inhibition of angiogenesis reduces following resection of theS. W. Kim and J. Wylie 3
primary tumour [13]. An activation of intrinsic antiangio-
genic factors may play a role in spontaneous regression of
cancer but an exact explanation of this remains an area for
research.
The immune system can be stimulated by several diﬀer-
ent factors including bacterial or viral infections, hormonal
inﬂuences, and trauma. In the original report on SR of
cancer by Everson and Cole, 71 patients had undergone an
operation and 8 had experienced infections before showing
spontaneous regression [14]. Since Cole (1981), there have
been numerous reports on spontaneous tumour regression
and many of them described the association between SR and
concomitant infections [15].
In the early part of 1900 William Coley, a surgeon
from New York, reported tumour regression in patients
following a streptococcal infection of an ulcerated tumour.
He subsequently showed that the immune system could
be stimulated through the administration of a vaccine
consisting of killed gram-positive Streptococcus pyogenes and
gram-negative Serratia marcescens, the so-called “Coley’s
toxins” [16]. Coley showed that the induction of a mild-
to-moderate fever was necessary to stimulate the immune
system suﬃcient to produce tumour regression. Although
Coley’s toxins are no longer routinely prescribed in standard
cancer management, a similar methodology explains the
response to superﬁcial bladder cancer following the intrav-
esicle administration of BCG [11]. Later studies have shown
that the SR of cancer following infection may be explained
by the release of cytokine and associated cellular immune
reaction results in inﬂammatory necrosis or T cell-mediated
apoptosis [17].
Changesintheactivityofnormalgenesarewellknownto
beresponsibleforthedevelopmentofcancer,and,asaresult,
any alterations in DNA methylation can contribute to the
malignant transformation of the cells [18]. Studies in genetic
alterations in carcinogenesis showed the frequent involve-
ment of genes that are inactivated by hypermethylations
with tumours that often undergo spontaneous regression
[19]. An increased response of tumour cells to the apoptotic
stimuli is also involved in the process of SR as well as the
activationofhostimmuneresponseinvolvingcytokinessuch
as interleukin and interferon gamma [20].
Spontaneous regression of pulmonary metastases from
an angiosarcoma is a rare event. A medline search found
similar reports on spontaneous regression of lung metas-
tases in patients with osteosacoma [21] and endometrial
stromal sarcoma [22] but there were no reports on SR
in angiosarcoma. Our patient had no history of recent
trauma or infection to suggest a stimulation of her immune
system as an explanation of this unusual phenomenon.
Seven months after her diagnosis with metastatic disease,
the patient remains stable without receiving any form of
treatment and the subcutaneous nodules in her scalp remain
controlled.
Inconclusion, spontaneous regression oflung metastases
in breast angiosarcoma is rare and its mechanism remains
uncertain. Further understanding of the exact pathways of
immune activation may help the development of anticancer
treatments.
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